Payers
Medicare, Medicaid won’t be required to cover GLP-1s for obesity, CMS says
Insurers have warned the proposed requirement would be costly.
Weight Loss
Pharma
AbbVie joins the weight loss race
In a $350m deal, AbbVie bought a Danish weight loss drug in Phase 1 clinical trials.
Pharma
Lawmakers, health experts call on FDA to pull Hims & Hers Super Bowl ad
Advocacy group and bipartisan letters urged the FDA to take action and pull the ad from running during Sunday’s game.
Pharma
Zepbound weight loss results better than Wegovy’s, Lilly study finds
While both drugs are GLP-1s, they have different active ingredients.
Payers
Biden’s proposal for government GLP-1 coverage could raise federal spending by billions
The administration proposed allowing Medicare and Medicaid to cover the drugs for weight loss, not just diabetes and cardiovascular disease.
Pharma
Pharma execs share their projections for the industry in 2025
From GLP-1s to AI, leaders share their thoughts.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
